STOCK TITAN

Freightos Ltd (CRGO) director receives 97,562 additional RSUs in amendment

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Freightos Ltd director Udo Lange reported an amended equity award that increases a prior restricted share unit grant. He received an additional 97,562 ordinary shares represented by RSUs, bringing the total grant to 121,952 ordinary shares represented by 121,952 RSUs.

The 121,952 RSUs will vest and settle in equal annual installments of 30,488 ordinary shares on each of the first four anniversaries of the original July 28, 2025 grant date, so all shares are due by July 28, 2029. Separate RSU-based ordinary share holdings began vesting on October 1, 2025 and vest quarterly through October 1, 2026, subject to board meeting attendance.

Lange also directly holds stock options over 100,000 ordinary shares at an exercise price of $5.00, 100,000 at $10.00, and 100,000 at $15.00 per share, all expiring on July 28, 2032, providing additional long-term equity exposure.

Positive

  • None.

Negative

  • None.
Insider Lange Udo
Role null
Type Security Shares Price Value
Grant/Award Ordinary Shares 97,562 $0.00 --
holding Stock Option (right to buy) -- -- --
holding Stock Option (right to buy) -- -- --
holding Stock Option (right to buy) -- -- --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
Holdings After Transaction: Ordinary Shares — 121,952 shares (Direct, null); Stock Option (right to buy) — 100,000 shares (Direct, null)
Footnotes (1)
  1. The transaction reported in this row consists of an amendment to an existing grant of restricted shares units ("RSUs") to the Reporting Person, which amendment was approved by the Issuer's board of directors on April 28, 2026. Under the amended terms, the Reporting Person received a finite number of additional ordinary shares represented by RSUs currently, with an annual vesting schedule, instead of being entitled to receive indeterminable numbers of additional ordinary shares at later dates based on the market price of the Issuer's ordinary shares at such later dates. Under the prior grant terms, the Reporting Person had been granted 24,390 ordinary shares represented by 24,390 RSUs that began vesting on July 28, 2025 and that were to vest (and settle for 24,390 underlying ordinary shares) on the one-year anniversary of the vesting commencement date (July 28, 2026) (in addition to indeterminable numbers of additional ordinary shares to be granted later). Under the revised grant terms, in lieu of those future grants, the Reporting Person received a finite, additional 97,562 ordinary shares currently, represented by 97,562 RSUs, such that the total grant has been set at 121,952 ordinary shares represented by 121,952 RSUs. The subject 121,952 ordinary shares consist of shares underlying 121,952 RSUs that will vest and settle in equal annual installments, for 30,488 ordinary shares each, on the first four anniversaries of the original July 28, 2025 grant date, such that all 121,952 ordinary shares will be received by the Reporting Person by July 28, 2029. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting on October 1, 2025 and that vest (and settle for underlying ordinary shares) equally on a quarterly basis (25% of the RSUs per quarter) such that all such RSUs will be vested by the one-year anniversary of the grant date (October 1, 2026). Vesting is subject to the Reporting Person's fulfilling minimum attendance requirements at meetings of the Issuer's board of directors.
Additional RSUs granted 97,562 ordinary shares Finite additional ordinary shares represented by RSUs granted under amended terms
Total RSU grant 121,952 ordinary shares Total ordinary shares represented by RSUs after amendment
Annual vesting installment 30,488 ordinary shares Equal annual installments on first four anniversaries of July 28, 2025
Option at $5.00 100,000 underlying shares Stock option exercise price $5.0000, expiration July 28, 2032
Option at $10.00 100,000 underlying shares Stock option exercise price $10.0000, expiration July 28, 2032
Option at $15.00 100,000 underlying shares Stock option exercise price $15.0000, expiration July 28, 2032
restricted shares units ("RSUs") financial
"The transaction reported in this row consists of an amendment to an existing grant of restricted shares units ("RSUs") to the Reporting Person"
vesting financial
"The subject 121,952 ordinary shares consist of shares underlying 121,952 RSUs that will vest and settle in equal annual installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
stock option (right to buy) financial
"Stock Option (right to buy) ... underlying security title Ordinary Shares"
exercise price financial
"Stock Option (right to buy) ... conversion_or_exercise_price "5.0000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date "2032-07-28T00:00:00.000Z" for the stock options reported"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lange Udo

(Last)(First)(Middle)
C/O FREIGHTOS LIMITED, PLANTA 10,
AVDA. DIAGONAL, 211

(Street)
BARCELONA08018

(City)(State)(Zip)

SPAIN

(Country)
2. Issuer Name and Ticker or Trading Symbol
Freightos Ltd [ CRGO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/28/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares04/28/2026A(1)97,562(2)A$0121,952(3)D
Ordinary Shares(4)48,084D
Ordinary Shares(4)15,432(5)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)(4)$1507/28/202807/28/2032Ordinary Shares100,000100,000D
Stock Option (right to buy)(4)$1007/28/202807/28/2032Ordinary Shares100,000100,000D
Stock Option (right to buy)(4)$507/28/202807/28/2032Ordinary Shares100,000100,000D
Explanation of Responses:
1. The transaction reported in this row consists of an amendment to an existing grant of restricted shares units ("RSUs") to the Reporting Person, which amendment was approved by the Issuer's board of directors on April 28, 2026. Under the amended terms, the Reporting Person received a finite number of additional ordinary shares represented by RSUs currently, with an annual vesting schedule, instead of being entitled to receive indeterminable numbers of additional ordinary shares at later dates based on the market price of the Issuer's ordinary shares at such later dates.
2. Under the prior grant terms, the Reporting Person had been granted 24,390 ordinary shares represented by 24,390 RSUs that began vesting on July 28, 2025 and that were to vest (and settle for 24,390 underlying ordinary shares) on the one-year anniversary of the vesting commencement date (July 28, 2026) (in addition to indeterminable numbers of additional ordinary shares to be granted later). Under the revised grant terms, in lieu of those future grants, the Reporting Person received a finite, additional 97,562 ordinary shares currently, represented by 97,562 RSUs, such that the total grant has been set at 121,952 ordinary shares represented by 121,952 RSUs.
3. The subject 121,952 ordinary shares consist of shares underlying 121,952 RSUs that will vest and settle in equal annual installments, for 30,488 ordinary shares each, on the first four anniversaries of the original July 28, 2025 grant date, such that all 121,952 ordinary shares will be received by the Reporting Person by July 28, 2029.
4. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
5. The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting on October 1, 2025 and that vest (and settle for underlying ordinary shares) equally on a quarterly basis (25% of the RSUs per quarter) such that all such RSUs will be vested by the one-year anniversary of the grant date (October 1, 2026). Vesting is subject to the Reporting Person's fulfilling minimum attendance requirements at meetings of the Issuer's board of directors.
Remarks:
Exhibit List - Exhibit 24.1 - Power of Attorney.
/s/ Max Sitnick, Attorney-in-fact04/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Freightos (CRGO) director Udo Lange acquire in this Form 4 filing?

Udo Lange received an additional 97,562 ordinary shares represented by restricted share units, increasing a prior grant to a total of 121,952 ordinary shares represented by 121,952 RSUs approved by Freightos’ board on April 28, 2026.

How will Udo Lange’s 121,952 Freightos (CRGO) RSUs vest over time?

The 121,952 ordinary shares underlying RSUs will vest and settle in four equal annual installments of 30,488 shares on each anniversary of the July 28, 2025 grant date, so all shares are scheduled to be received by July 28, 2029.

What other RSU-based Freightos (CRGO) share holdings does Udo Lange report?

One RSU grant began vesting on October 1, 2025 and vests quarterly, with 25% of the RSUs vesting each quarter so that all such RSUs are fully vested by the one-year anniversary on October 1, 2026, subject to meeting attendance requirements.

What stock options in Freightos (CRGO) does Udo Lange hold according to this filing?

Lange holds stock options giving rights to buy 100,000 ordinary shares at $5.00, 100,000 at $10.00, and 100,000 at $15.00 per share, all expiring on July 28, 2032, each referencing underlying ordinary shares.

Does this Freightos (CRGO) Form 4 show any open-market share purchases or sales?

The Form 4 shows a grant or award acquisition of 97,562 RSU-based ordinary shares and several holding entries, but no transactions are identified as open-market purchases or sales; some rows are explicitly described as informational only.